Symptoms may include: Rash or hives Itching/swelling of face, tongue, or throat Severe dizziness Difficulty breathing Side Effect 4: Cardiovascular Concerns Some patients may experience cardiovascular-related side effects, including irregular heartbeat and chest pain
After a 36-week treatment, patients were randomised into two arms one where treatment was continued and a placebo arm where it was stopped
Clinical Evidence: GLP-1 and Cardiovascular Health Major clinical trials including SUSTAIN-6 (semaglutide) and SURPASS (tirzepatide) documented cardiovascular outcomes in patients with type 2 diabetes and obesity
BPC-157 is often discussed for joint, tendon, and gut-related inflammation, while TB-500 is commonly explored for systemic recovery and tissue repair
The first truly selective GH secretagogue: no stimulation of ACTH, cortisol, or prolactin, even at doses 200 higher than ED
Reach out to us at 949-460-9111